Abstract: Suprascapular nerve blockade (SSNB) is a simple and safe technique for providing relief from various types of shoulder pain, including rheumatologic disorders, cancer, and trauma pain, and postoperative pain due to shoulder arthroscopy. Posterior, superior, and anterior approaches may be used, the most common being the posterior. Recently, an ultrasound-guided approach has been described. In this review, the basic anatomy of the suprascapular nerve will be described. The different techniques of SSNB and indications for SSNB will be discussed. The complications of SSNB and outcomes of SSNB on the management of acute and chronic shoulder pain will be reviewed. (Reg Anesth Pain Med 2011;36: 358Y373) 
T he suprascapular nerve (SSN) is the major sensory nerve to the shoulder, especially in the posterior and superior aspect. 1 For pain originating from the shoulder and associated structures, the SSN is an accessible target for blockade. Suprascapular nerve blockade (SSNB) was first described in 1941 by Wertheim and Rovenstein. 2 Since then, SSNB has been applied in the management of acute 3, 4 and chronic pain, 5 as well as for the diagnosis of suprascapular neuropathy. 6 Specific chronic shoulder pain syndromes in which SSNB has been used include rheumatoid arthritis, 5, 7, 8 osteoarthritis 9 of the glenohumeral joint, and various rotator cuff disorders including frozen shoulder.
5,10Y13
Recently, renewed interest in this technique has arisen owing to the potential for improved control of moderate to severe postoperative pain that follows open-and closed-shoulder surgery. 3, 4, 14, 15 There have been numerous variations and refinements in the technique of SSNB since its introduction. The implementation of imaging guidance with ultrasound (US) most recently has attempted to improve the accuracy of blocking the SSN. 16Y18 Furthermore, use of lesioning techniques such as pulsed radiofrequency (RF) to provide sustained analgesia has also been described in the literature. 19, 20 Despite these developments, the place of SSNB in pain management is not clearly defined.
In this review, the basic anatomy of the SSN and different approaches of SSNB will be briefly described. The outcomes of SSNB in the management of acute and chronic shoulder pain will be reviewed. The possible complications of SSNB will be discussed. A summary of the evidence level for the use of SSNB will be presented.
REVIEW METHODS
We performed a literature search for journal articles written in English in the PubMed database from January 1986 to December 2010. The electronic search strategy contained the following medical subject headings and free text terms: suprascapular nerve block, pain management, and complications of suprascapular nerve block. We excluded trials before 1986 because these were deemed out of date and superseded by more recent studies in terms of clinical evidence. We excluded abstracts older than 3 years, isolated case reports (eg, cancer pain), and correspondence articles. Although we included articles involving a case series, we limited these to studies involving more than 10 patients unless the series contained some very interesting findings.
ANATOMY OF THE SSN
The SSN is a large peripheral nerve possessing both motor and sensory fibers. It originates from the ventral rami of the fifth and sixth cervical nerve roots. 21, 22 In addition, there may be a variable contribution from the fourth cervical nerve root. 21, 23 After its formation, the nerve emerges from the lateral aspect of the upper trunk of the brachial plexus. It then travels through the posterior triangle of the neck, courses deep to the trapezius and omohyoid muscles, and enters the supraspinous fossa via the suprascapular notch underneath the superior transverse scapular ligament (STSL; Fig. 1 ). The suprascapular artery and vein pass above this ligament. 24 In the supraspinous fossa, the nerve is in direct contact with bone and exits the suprascapular fossa to infrascapular fossa lateral to the spinoglenoid notch 24 ( Fig. 2 ). Shortly after passing through the suprascapular notch, the SSN emits 2 branches: one is the motor nerve for the supraspinatus muscle 24Y26 and the other is known as the superior articular branch. The latter nerve is sensory and supplies the coracoclavicular, coracohumeral ligaments, the acromioclavicular joint, glenohumeral joint (posterior and superior aspects), and the subacromial bursa. 21, 27, 28 The main trunk then exits the suprascapular fossa by curving around the lateral border of the scapula spine through a fibro-osseous tunnel terminating in motor branches to the infraspinatus muscle 26, 28 (Fig. 2) . The fibro-osseous tunnel is formed by the spinoglenoid ligament and the spine of the scapula. 29 The number of terminal motor branches supplying infraspinatus is variable and ranges from 2 to 4.
24Y26
The anatomy of the suprascapular notch is important for several reasons. The nerve is susceptible to injury and impingement at the level of the notch as it passes beneath the STSL. 30, 31 This site represents an attractive region for SSN blockade as the nerve has not divided yet. The variable shape of the notch has been described and has been categorized into different types 32, 33 (Fig. 3) . In the adult, the most common type is a U-shaped or semicircular notch (types 1 and 2 in Fig. 3) . 32 In one anatomic study of the scapula, the notch is absent or converted into a foramen by the ossified STSL in 15% of the specimens. 33 
TECHNIQUE OF LOCALIZING THE SSN
The details of the individual techniques will not be described here, but the two major approaches, superior and posterior, are compared below. In addition, the roles of various image-guided injections are discussed.
Approaches
Using surface landmarks, the SSN may be localized via a posterior or superior approach. While the posterior approach attempts to block the SSN at the level of the suprascapular notch, 2,34Y37 the superior approach aims to block the SSN by surrounding the nerve with local anesthetic on the floor of the supraspinous fossa.
38,39

Posterior Approach
The posterior approach is generally performed while the patient sits on the operating table with the ipsilateral arm lying at his or her side. 2, 35, 40 The superficial landmarks described in the posterior approach techniques serve to guide the needle to slide into the notch. As discussed in the anatomy section, the notch is not a defined structure in 15% of the population. Furthermore, the potential complication of this approach is pneumothorax as the trajectory of the needle is toward the thoracic cavity. The classic (Wertheim) approach is well described in the literature. 2 Modification of the landmarks for needle placement has been made by several authors. 34Y37 To avoid the risk of pneumothorax, the scapula can be elevated from the posterior chest wall by repositioning the ipsilateral hand to the opposite shoulder, thereby increasing the potential distance the needle must travel from the skin to chest wall. 41 To improve accuracy, the SSN has been localized using a nerve stimulator, 4,14 paresthesia, 41 and electromyography (EMG). 42 
Superior Approach
The superior approach 38, 39 was initially described to permit SSNB performed in patients in the supine position, but the sitting position is the preferred position in clinical practice. In general, the needle is directed to the lateral half of the floor of the suprascapular fossa because the supraspinatus muscle is attached to the medial half. Potential advantages of this approach include ease of access, no reference to the notch, and extremely low risk of pneumothorax.
38,39
Comparison of Blind Approach
Despite the many approaches and techniques published to date, few studies have actually compared them. An old study on pulsed RF lesioning of the SSN 43 compared four commonly used blind techniques, 2, 34, 37, 44 in the final position of the needle tip relative to the suprascapular notch with radiographic correlation. They found that the needle tip was usually a significant distance from the notch such that a heat lesion would not affect the SSN in all techniques. When comparing the blind methods, they found that the approach suggested by Granirer 37 offered the best approximation of ''needle tip to notch.'' 43 
Methods to Improve the Accuracy
Techniques using imaging guidance such as fluoroscopy, 45 computed tomography (CT), 46 and, more recently, US 16, 17, 47 have been described.
Conventional Imaging
Fluoroscopy and CT have been described to locate the suprascapular notch. 45, 46 For the fluoroscopic technique, the patient is placed in the prone position. A C-arm is then used to identify the notch. 45 The suprascapular notch will be seen superior to the spine of the scapula, medial to the coracoid process, and lateral to the rib margins (Fig. 4) . 45 To obtain an optimal Br.IS, branch to the infraspinatus muscle; Br.SS, branch to the supraspinatus muscle; CP, coracoid process; SS, scapula, spine; TSL, transverse scapula ligament. Reproduced with permission from Ultrasound for Regional Anesthesia (www.usra.ca).
FIGURE 2. Superior view of the left shoulder. The course of the suprascapular nerve (shaded) enters the suprascapular fossa through the suprascapular notch (SSNo) and then enters the infrascapular fossa through the spinoglenoid notch (SGNo). Reproduced with permission from Ultrasound for Regional Anesthesia (www.usra.ca).
image, the C-arm will often need to be obliquely angled away from the side of the proposed block and in the cephalocaudad orientation. 45 
Ultrasound-Guided SSNB
Recently, several articles have been published describing the technique of US-guided SSNB. 16, 17, 47, 48 As US-guided SSNB is a more recent technique and offers the visualization of the SSN, suprascapular artery, and the muscle layers, it will be discussed in further detail.
The ideal site to perform SSNB with US is at the floor of the suprascapular fossa, between the suprascapular notch and the spinoglenoid notch 17 (Figs. 2 and 5A , B). At this site, the SSN runs along the floor of the suprascapular fossa covered by the fascia of supraspinatus in a natural compartment, which will contain the spread of the local anesthetic or injectate. Applying a US-guided injection technique approximated the needle tip to the nerve and has been shown to achieve a complete block with a reduced volume of local anesthetic. 49 A small volume (5 mL) of injectate will result in adequate flooding of the nerve 50 with minimal spread to the brachial plexus. 51 Furthermore, this target is independent of the suprascapular notch, which can be absent in some individuals. The risk of pneumothorax is substantially reduced because of the direction of the needle.
52
Imaging and EMG to Improve Needle Localization of the SSN Despite multiple techniques being published describing assistance in needle localization, few data exist to guide the clinician on the effectiveness of this technology. In EMG guidance, 1 randomized clinical trial compared landmark-based to EMG-guided SSNB. 42 The patient population consisted of patients with chronic pain with adhesive capsulitis. 42 Although pain scores and shoulder range of motion (ROM) improved after SSNB in both groups, the investigators found that the EMG group had significantly lower pain scores than the landmarkbased injection group. However, the follow-up was short, only 60 mins after procedure. It is unclear how relevant this finding is for a chronic pain problem.
One randomized single-blind trial compared the blind approach to SSNB with a CT-guided approach. 9 This study did not 85%) ; type III, notch with greater vertical diameter, S1 (41.85%); type IV, bony foramen (7.3%); type V, notch with bony foramen (0.7%). Adapted from Natsis et al. 33 Reproduced with permission from Ultrasound for Regional Anesthesia (www.usra.ca).
Chan and Peng
Regional Anesthesia and Pain Medicine & Volume 36, Number 4, July-August 2011 find any significant difference between the blind or CT-guided SSNB in pain scores, disability. 9 Both groups showed significant improvement after SSNB. 9 There were no significant adverse effects in either group, and patient satisfaction scores were high. 9 Recently, the efficacy of US-guided SSNB was compared with the landmark-based technique. 18 In this study, patients with chronic nonspecific shoulder pain were randomized with 25 patients in each group. The investigators found that, initially, both groups improved in terms of pain relief. However, the analgesic effect was better sustained at 1 month in the US-guided group compared with the control group. 18 Furthermore, although there were no complications in the US-guided group, the control group recorded 2 cases of arterial puncture and 3 cases of direct nerve injury with neurologic deficit. 18 In summary, various approaches have been described for the blockade of SSN. Disadvantages of the approach using the notch as a landmark are the potential absence of the notch in some individuals and the potential risk of pneumothorax. The superior approach may negate these disadvantages. On limited evidence, these studies would suggest that US is useful in approximating the block needle near the SSN and thereby in increasing efficacy and reducing complications of SSNB.
SUBSTANCES USED FOR BLOCKADE OF THE SSN
When the needle is placed near the SSN, several methods of nerve blockade have been published. The commonly used methods include local anesthetic, steroids, pulsed RF, and chemical neurolysis. These may be used alone or in combination. Bupivacaine is the popular local anesthetic agent, either in the concentration of 0.25% 12, 38, 41 or 0.5% 7, 8, 14, 39 described in the literature. Epinephrine (1:200,000) is commonly added to the local anesthetic solution to increase the duration of action. 8 Injectate volume is highly variable in the literature. However, some authors argue that 5 mL is the optimal volume based on morphologic evidence. 50 For the treatment of chronic shoulder pain, injectable steroid (methylprednisolone) is usually added to the local anesthetic solution. However, the value of this practice has been questioned by a double-blinded study 8 demonstrating that the addition of methylprednisolone fails to confer any benefit. Suprascapular nerve blockade achieved with RF or cryolesion provides a long-lasting effect that can endure for up to 18 months. 20, 43, 53 Furthermore, one of these studies demonstrated a significant reduction in pain, improvement in function, and a reduction in analgesic medication (81% of study patients) after pulsed RF of the SSN. 20 The use of chemical neurolysis for SSNB has mainly been in the form of case reports. 43, 54 Injection of phenol causes protein coagulation and necrosis when applied directly to the nerve, thereby alleviating pain. A larger study involved 16 patients with shoulder pain secondary to rheumatoid arthritis. These patients received SSNB with prilocaine (4 mL) and 6% aqueous phenol (4 mL) with significant reduction in pain and improved shoulder ROM at 13 weeks of follow-up. 55 
SUPRASCAPULAR NERVE BLOCKADE IN CLINICAL PRACTICE
Suprascapular nerve blockade has been used in acute and chronic pain states. For acute pain, SSNB has been mainly achieved using long-acting local anesthetic solutions alone.
Acute Pain
The studies investigating the efficacy of SSNB in acute pain states are summarized in Table 1 .
Suprascapular nerve blockade has been used successfully for the control of postoperative pain after open and arthroscopic shoulder surgery (Table 1) . 4, 14, 56, 57, 62 It has been used as the sole regional anesthetic technique 4, 56, 57 but also in combination with other nerve blocks. 3, 15, 61 Although shoulder arthroscopy recently has become popular as an outpatient procedure, it remains one of the most painful of the same-day surgical procedures. 63 Use of interscalene block had been shown to reduce the unanticipated readmission rate due substantially to pain. 63 At present, interscalene brachial plexus block (ISB) is the usual regional technique used for analgesia during and after shoulder surgery. 64Y66 Blockade of the brachial plexus provides more complete analgesia of the shoulder joint. Because the SSN supplies 70% of the sensory input to the shoulder joint, SSNB allows good control of severe postoperative pain after this notoriously painful procedure. Suprascapular nerve blockade decreases pain scores at rest and with movement in the early postoperative period and alleviates pain at 24 hours on shoulder abduction. 4 Furthermore, a significant reduction in analgesic dose and demand, discharge time, and the incidence of nausea has been reported. 4 
FIGURE 5.
A, Ultrasonographic image of the suprascapular nerve on the floor of the scapular spine between suprascapular notch and spinoglenoid notch. Both suprascapular nerve and artery run underneath the fascia of supraspinatus muscle. Suprascapular A and N indicate suprascapular artery and nerve. Bold arrows outline the floor of the scapula fossa. B, Approximate position of the ultrasound probe (dark rectangle). The patient can be in sitting or in prone position. Ultrasound scanning is performed with a linear ultrasound probe (7Y13 MHz) placed in a coronal plane over the suprascapular fossa with a slight anterior tilt. The probe is place in an orientation such that it is in the short axis to the line joining coracoid process and acromion (reflecting the position of the spinoglenoid notch). The trapezius muscle was removed to show the underlying supraspinatus muscle. Reproduced with permission from Ultrasound for Regional Anesthesia (www.usra.ca). Singelyn et al 57 conducted a study comparing control group (no regional technique), ISB, intra-articular local anesthetic, and SSNB after arthroscopic acromioplasty. In the first 24 hours of follow-up after surgery, both ISB and SSNB provided significantly improved pain control compared with the control group. 57 Intra-articular local anesthetic was not significantly different from controls. 57 However, at 4 hours of follow-up, ISB provided superior analgesia to the SSNB. 57 Only ISB produced significant reduction in morphine consumption compared with controls. 57 The authors concluded that ISB provided the most effective and efficient analgesic technique but that SSNB was an appropriate alternative especially in patients with pulmonary compromise because SSNB does not affect pulmonary function. 57 The superior analgesia with ISB compared with SSNB is no surprise because, at best, SSNB can only anesthetize 70% of the shoulder joint. The remaining sensory innervation is provided by the nerve to the subscapularis, axillary nerve, and lateral pectoral nerve. 1 To improve the success rate of this regional technique, several clinicians have combined SSNB with an axillary nerve block to provide increased coverage of the shoulder joint during shoulder surgery. 3, 61, 67 Only 1 comprehensive study has been performed, and this was limited to arthroscopic procedures for rotator cuff disorders. 3 With the combined SSNB and axillary nerve block technique, all the patients in the study were able to undergo the operation with only sedation. 3 No opioid analgesics or general anesthesia was required. 3 The major limitations of these studies have been that they are case series and not randomized controlled trials.
The studies discussed previously are limited to arthroscopic shoulder surgery. For nonarthroscopic/open shoulder surgery, the role of SSNB is limited. 15 Neal et al 15 conducted a randomized clinical trial comparing standard ISB with ISB plus SSNB for nonarthroscopic shoulder surgery. They found that as an adjunct, SSNB provided more prolonged analgesia compared with ISB alone but did not affect other outcome measures such as supplemental analgesic use or quality-of-life outcomes. 15 They concluded that SSNB is less useful for nonarthroscopic shoulder surgery because these operations are usually anterior procedures that are outside the region of SSN sensory innervation compared with the posterior port stimulation of arthroscopic surgery. 15 In summary, for pain associated with shoulder surgery, ISB is the most effective regional technique for analgesia and ambulatory outcome measures. Suprascapular nerve blockade will provide improved analgesia compared with a general anesthetic technique alone for arthroscopy but is inferior to ISB. Suprascapular nerve blockade combined with an axillary nerve block provides excellent operative and postoperative analgesia. For nonarthroscopic shoulder surgery, the role of SSNB as an adjunct to ISB is limited.
In addition to the management of acute pain associated with shoulder surgery, several studies have assessed SSNB for control of shoulder pain after thoracotomy. 58Y60 These studies provided conflicting results. Whereas 1 retrospective study demonstrated a reduction in shoulder pain after thoracotomy in patients treated with SSNB, 59 two prospective randomized studies did not show any reduction in shoulder pain in patients receiving SSNB for shoulder pain after thoracotomy. 58, 60 Furthermore, the most recent randomized controlled trial suggested that shoulder pain after thoracotomy is not musculoskeletal in origin but referred pain from diaphragmatic irritation. 58 The difference in results may be due to the selection of patients. The study demonstrating that SSNB was beneficial in screening postthoracotomy patients and only those with shoulder pain and localizing signs suggestive of musculoskeletal pain improved with SSNB. 59 In summary, one may conclude that SSNB is not effective in all patients who develop ipsilateral shoulder pain after thoracotomy. However, in those patients who have localizing signs suggesting the shoulder pain is musculoskeletal in origin, SSNB is an appropriate intervention to relieve pain. This could be further investigated by a randomized clinical trial.
The efficacy of SSNB has been reported in a variety of other acute pain states 68Y70 ; these were limited to isolated case reports or small case series and, although promising, require further investigation.
Chronic Pain
For patients with chronic pain, SSNB may be both a diagnostic but more commonly a therapeutic procedure. To achieve more prolonged analgesia for chronic pain, local anesthetic is combined with steroid, phenol, or pulsed RF when SSNB is performed (Table 2) .
Diagnostic Block for Suprascapular Neuropathy
Suprascapular neuropathy is believed to be the cause in 1% to 2% of patients with shoulder pain. 74 The suspicion of suprascapular neuropathy is suggested by posterior shoulder pain, a history of trauma or traction to the SSN, and weakness and atrophy of the muscles (supraspinatus, infraspinatus) supplied by the SSN. 29 ,75Y77 Neuropathy of the SSN can be caused by traction or compression of the nerve at the spinoglenoid region or the suprascapular notch. The causes of traction or compression include trauma, repetitive use, and space-occupying lesions. 78, 79 The differential diagnosis is broad. The diagnosis is often made based on clinical, investigative parameters (electrophysiologic and imaging studies) and on exclusion of other pathologic diseases, mainly rotator cuff pathology, cervical radiculopathy, and brachial plexopathy. 80 The optimal management of suprascapular neuropathy has not been determined. Studies have reported good to excellent results in either nonsurgical management 81, 82 or surgical management. 74, 75, 77 Owing to the difficulty in differentiating suprascapular neuropathy from other shoulder pathologic diseases, SSNB can be performed to aid in the diagnosis. 6 A diagnosis of SSNB is often based on clinical history and examination findings together with electrodiagnostic studies and magnetic resonance imaging. 6 In cases where the diagnosis is uncertain after electrodiagnostic studies, SSNB may be helpful. The test is positive if the pain is completely relieved. 78 
Chronic Shoulder Pain: General Considerations
Suprascapular nerve blockade has been widely investigated in a variety of chronic pain conditions (Table 2) . A number of trials, which examined chronic shoulder pain in a heterogeneous group without looking at individual pathologic diseases, have been performed. 18, 20, 46, 53, 72 Of these trials, three were randomized. 18, 53, 72 Two of these randomized studies compared SSNB to intra-articular steroid for shoulder pain and function. 53 The other study compared SSNB under US to SSNB via surface anatomy. 18 In these trials, SSNB resulted in significant improvements in pain scores and shoulder function.
There is only 1 randomized controlled trial that investigated chronic shoulder pain of either degenerative disease or inflammatory in origin. 5 This investigation revealed a significant and sustained benefit in pain and disability scores as well as the range of movement at weeks 1, 4, and 12. 5 The remaining trials consisted of case series, which showed significant improvement in pain and disability in chronic nonspecific shoulder pain after SSNB. 20, 46 The most common pathologic diseases individually studied are chronic pain from rheumatoid arthritis or osteoarthritis, adhesive capsulitis (frozen shoulder), and persistent rotator cuff lesions.
Shoulder Joint Arthritis: Rheumatoid Arthritis and Osteoarthritis
A number of studies have assessed the efficacy of SSNB for the pain and disability of arthritis. Some have included both osteoarthritis and rheumatoid arthritis, 5,9,55 whereas others have focused on rheumatoid arthritis alone. 8, 43 Shoulder pain is common in patients with rheumatoid arthritis. Early in this disease process, 40% of patients have shoulder involvement, with nearly all eventually having shoulder pain and disability. 83 The causes of shoulder pain in this population include arthritis in the glenohumeral and acromioclavicular joint, rotator cuff disease, subacromial bursitis, tenosynovitis, and referred pain from cervical spine disease. 83 The goal of SSNB is to provide better shoulder pain control and movement in patients with long-standing rheumatoid arthritis.
Local intra-articular corticosteroid injection and gentle mobilization may improve rheumatoid shoulder in the early stages of disease. 83 However, when glenohumeral damage is advanced, this treatment option is not as effective. 84 Two randomized controlled trials have been published to suggest the efficacy of SSNB. One is a randomized controlled trial comparing the efficacy of intra-articular steroid injection with SSNB in patients with long-standing rheumatoid arthritis (mean, 17 years), SSNB provided prolonged pain relief (3 mos) and superior improvement in shoulder movement. 7 Another one is a double-blind placebo-controlled randomized controlled trial including patients experiencing rheumatoid shoulder that was performed recently. 5 A total of 108 subjects were randomized to receive an injection of 10 mL of bupivacaine 0.5% and 40 mg of methylprednisolone into the suprascapular fossa or a placebo injection of 5 mL of normal saline. 5 Suprascapular nerve blockade was performed using surface anatomic landmarks as described by Dangoisse et al. 39 At 3 months of follow-up, the active injection (local anesthetic and steroid) group recorded significantly superior pain reduction (visual analog scale) and functional improvement (Shoulder Pain and Disability Index, SF-36 scales) compared with the placebo group. A notable finding was that 67% of the patients receiving the active injection improved by at least 10 points on the Shoulder Pain and Disability Index, which is a significant clinical improvement. 85 The only adverse effects were minor including chest wall tenderness in one subject, which resolved, and minor bruising in another subject. 5 Similarly, SSNB provided significantly better analgesia and superior movement in patients with long-standing rheumatoid arthritis who were unresponsive to intra-articular injection of steroid. 8, 43 Interestingly, supplementation of the local anesthetic solution with steroid conferred no additional benefit. 8 
Adhesive Capsulitis (Frozen Shoulder)
Also known as adhesive capsulitis, frozen shoulder is characterized by significantly restricted shoulder movement in patients with shoulder pain. 12 This condition progresses from pain to pain accompanied by gradually worsening stiffness to reduced pain accompanied by profound stiffness. The last stage seems to be self-limiting and recovery is gradual and spontaneous, with an excellent chance of complete return of function within 1 to 2 years irrespective of therapy. 86, 87 The goal of treatment in the early stage is to alleviate pain so that physiotherapy can be effective in restoring normal shoulder movement and activity. 87 A comparative clinical trial performing SSNB on patients with adhesive capsulitis demonstrated a significant improvement in pain and ROM scores, but follow-up was limited to only 90 minutes after SSNB with local anesthetic alone. 42 Furthermore, there was no placebo control. 42 A small randomized trial (30 patients) compared the effects of SSNB to intra-articular shoulder injections for adhesive capsulitis during a longer follow-up period. 73 The investigators found that SSNB produced faster onset and more effective analgesia compared with a series of intra-articular injections. 73 Furthermore, significantly improved shoulder function (measured by abduction and external rotation) was also observed. 73 These effects lasted up to 3 months. 73 A later placebo-controlled trial examined the response of SSNB with bupivacaine compared with placebo. 13 There was a significant reduction in pain in patients receiving local anesthetic blockade up to 1 month of follow-up. 13 However, no significant improvement in shoulder function or range of movement was found. This study did not inject steroid medication as part of their treatment. 13 
Persistent Rotator Cuff Lesions
Rotator cuff tendinitis is a common cause of shoulder pain in adults and may result in considerable morbidity. 88, 89 Many patients respond to conservative management, including avoiding activities likely to aggravate the lesion, use of nonsteroidal anti-inflammatory drugs, local injection of steroid, and physiotherapy. 88, 89 However, significant symptoms may persist: in one retrospective, long-term follow-up study, symptoms of severe shoulder pain persisted in approximately 26% of patients after a mean duration of 12 months after the first presentation of pain. 89 In this subset of patients with persistent symptoms, SSNB has been demonstrated to provide effective pain relief and improved ROM. 11 Although the therapeutic effect is temporary (4Y12 weeks), it can be simply repeated in outpatient settings with minimal risk of complications. This block is also an effective way to control pain in patients awaiting surgery. 11 Recently, pulsed RF of the SSN has shown promise in providing prolonged analgesia for those patients responding to SSNB (rotator cuff lesion identified on clinical and radiologic grounds) but where analgesia is not sustained. 19 After pulsed RF lesioning, a significant reduction in pain (visual analog scale) and improvement in shoulder function (Constant and Oxford shoulder scores) was reported, lasting until 3 months of follow-up. 19 These results are similar to those of Liliang et al 20 who, in addition to improvement in pain and function, also demonstrated a reduction in medication requirements in their study group. However, both injection and RF trials did not include a placebo control group, and further investigation is required to confirm the efficacy of the neural blockade or ablation technique in the management of rotator cuff tendinitis.
In summary, SSNB is effective for short-term pain relief and improvement in shoulder function in a variety of painful shoulder conditions. The main causes of shoulder pain studied were arthritic conditions, rotator cuff lesions, and adhesive capsulitis. Unfortunately, in many studies, the patient population was heterogeneous with regard to shoulder pathology. Therefore, interpreting specifically which pathologic disease responds best to SSNB is difficult to determine. Pulsed RF to the SSN has shown promise in providing more sustained analgesia and functional improvement. However, these studies have mainly involved case series.
SUPRASCAPULAR NERVE CATHETER
Although SSN catheters have been used, published reports are limited to isolated cases or small case series. 90, 91 In one cancer case, prolonged analgesia from pain due to metastasis to the scapula was achieved by repeated injection through an epidural catheter, which was advanced into the suprascapular space. 91 The catheter was tunneled subcutaneously, exiting into the supraclavicular area, permitting treatment of breakthrough pain from scapular movement by repeated injection of 0.5% bupivacaine. 91 A more recent correspondence described placement of the catheter at the spinoglenoid notch during shoulder arthroscopy. 90 This is done under direct vision by the surgeon. 90 However, more outcome data are required to assess whether this would be beneficial for postsurgical pain compared with a single-shot SSNB.
COMPLICATIONS
The complication rate of SSNB is generally low (Table 3) . Possible complications are discussed.
Pneumothorax
Although rare (incidence G1% 34 ; Table 1 ), pneumothorax is the most serious complication of SSNB. It usually occurs with the posterior approach and is caused by advancing the needle deeper than recommended. The usual depth of needle at which bone contact is made is between 3 and 6.3 cm. 34, 41, 92 When inserted more than 5 cm, the needle is likely to be at the suprascapular notch or above the scapula border. To reduce the risk of pneumothorax, the needle should be withdrawn and redirected at a slightly different angle until the bone is reached. In addition, positioning the ipsilateral hand to the opposite shoulder will elevate the scapula away from the posterior chest wall, thereby increasing the potential distance between the skin and the chest wall 41 and minimizing the risk of unintentional pneumothorax. Penetration of the intercostal space also is unlikely with the superior approach. For the superior approach, 39 the needle is advanced in a direction parallel to the scapula and away from the direction of the lung; with the anterior approach, the point of needle entry is away from the dome of the lung and the needle is advanced in a direction perpendicular to the ribs. 12 
Intravascular injection
The suprascapular artery and vein are separated from the nerve by the superior transverse ligament of the scapula. 22 Puncture of either vessel during needle insertion may produce a systemic toxic reaction after administration of local anesthetic. Thus, careful aspiration is essential before injection of the local anesthetic to ensure the absence of vascular puncture.
Residual motor block
Suprascapular nerve blockade reportedly has resulted in impaired motor function, but the duration and significance of this effect have not been defined or confirmed. In addition, the supraspinatus and infraspinatus are the only muscles supplied by the SSN, making profound motor blockade unlikely, in contrast to interscalene block. 93 
Local trauma
Repeated probing during localization of the suprascapular notch can result in significant trauma, particularly in muscular patients. In addition to aching at the needle insertion site (Table 1) , the patient may also have a vasovagal response. 94 
SUMMARY AND FUTURE DIRECTIONS FOR RESEARCH
On review of the literature discussed here, the uses of SSNB and pulsed RF lesioning of the SSN can be summarized in Table 4 .
Although the studies mentioned in this review demonstrate efficacy of SSNB in chronic shoulder pain, there is a lack of placebo-controlled trials to provide robust evidence. Many of the trials were either case series or compared SSNB to another intervention for shoulder pain (eg, intra-articular steroid injection). The beneficial effect of placebo in the reduction of pain has been well documented. 96 Therefore, future trials should incorporate a placebo control when studying SSNB or other methods of lesioning the SSN with the intent of reducing shoulder pain. 53 Pulsed RF of the SSN has been proposed to provide more sustained analgesia than single-shot SSNB. Several trials have reported promising results but have been nonrandomized, comprised low numbers, studied a heterogeneous population, and have limited follow-up. Although this review has concentrated on SSNB, the importance of physical therapy in patients with chronic shoulder pain cannot be ignored. Future research would be helpful in identifying the best timing for SSNB in conjunction with physical therapy. Would SSNB performed earlier lead to improved results rather than waiting for a patient to fail standard conservative medical treatment? Furthermore, with the complication rate from SSNB being very low, is the benefitto-risk ratio much improved by performing SSNB earlier in patients with chronic shoulder pain?
Perhaps the major limitation identified in reviewing the literature is that many trials did not differentiate the efficacy of SSNB on different shoulder pathologic diseases. Many trials were on heterogeneous populations experiencing chronic shoulder pain. This would include patients with osteoarthritis or rheumatoid arthritis, rotator cuff lesions, and myofascial pain. By including a heterogeneous population, the external validity of these studies is reduced. Future research should attempt to identify which specific shoulder pathologic diseases SSNB is effective for. This, in turn, would better assist the clinician to better select patients who should receive SSNB as part of their management.
CONCLUSIONS
Suprascapular nerve blockade is easy to perform and a safe technique for providing relief from various types of shoulder pain. Suprascapular nerve blockade permits effective, longlasting analgesia for conditions affecting the shoulder or scapula, including rheumatologic disorders, cancer and trauma pain, and postoperative pain due to shoulder arthroscopy. Posterior, superior, and anterior approaches may be used, the most common being the posterior. Pneumothorax is the most significant, albeit rare, complication of SSNB, the risk of which can be minimized by vigilance to the depth of needle insertion and to contact with bone, positioning of the patient's ipsilateral hand to the contralateral shoulder, depositing injectate to the supraspinous fossa rather than the suprascapular notch, and using the superior rather than posterior the approach.
Future research should seek to better identify which shoulder pathologic diseases will respond to SSNB. In addition, the timing and place of SSNB as part of a multidisciplinary pain management program deserves further study. 97 
TABLE 4. Summary of Evidence on Suprascapular Nerve Block and Rhizotomy
Studied Uses of SSNB Level of Evidence
SSNB is inferior to ISBPB for shoulder surgery I SSNB is not effective for reducing all cases of ipsilateral shoulder pain after thoracotomy I SSNB does not improve outcomes in ambulatory nonarthroscopic shoulder surgery when added to ISBPB I SSNB is effective for postoperative pain control for shoulder arthroscopic surgery and reduces opioid requirements and nausea and vomiting II-1 SSNB is effective for providing short-term (3 mo) analgesia and improving function for chronic shoulder pain due to degenerative pathology or rotator cuff lesions II-1 PRF of the SSN can provide longer lasting analgesia and improved shoulder function than single SSNB II-2 SSNB combined with axillary nerve block is sufficient for arthroscopic shoulder surgery II-3
Based on the Quality of Evidence Grading as recommended by the US Preventive Services Task Force (Appendix 1). 95 ISBPB indicates interscalene brachial plexus block; PRF, pulsed radiofrequency; SSN, suprascapular nerve; SSNB, suprascapular nerve block.
